Thus, serum Ang2 level is a candidate biomarker for the presence of liver diseases such as nonalcoholic steatohepatitis (NASH) [35] and mortality in decompensated LC with kidney dysfunction [36]. The gene discussed is ANGPT2; the disease is metabolic dysfunction-associated steatohepatitis.